Millendo Therapeutics, Inc. $50,000,000 Shares Common Stock ($0.001 par value) Amended and Restated Equity Distribution AgreementEquity Distribution Agreement • March 4th, 2020 • Millendo Therapeutics, Inc. • Pharmaceutical preparations • New York
Reference is made to the Equity Distribution Agreement dated April 5, 2019 (the “Original Equity Distribution Agreement”) by and between Millendo Therapeutics, Inc., a Delaware corporation (the “Company”), and Citigroup Global Markets Inc. (“Citigroup”), pursuant to which the Company agreed, in its sole discretion, to issue and sell, from time to time, through Citigroup, as sales agent, shares of the Company’s common stock, par value $0.001 per share, having an aggregate offering price of up to $50,000,000 (the “Shares”). The Company, Citigroup and SVB Leerink LLC (“SVB Leerink”) (together with Citigroup, collectively, the “Managers”, and each individually a “Manager”) wish to amend and restate the Original Equity Distribution Agreement in its entirety as provided hereby.
